Organizing Pneumonia in Rheumatoid Arthritis Patients: A Case-Based Review [0.03%]
类风湿关节炎患者的组织细胞肺炎：病例综述
Shunsuke Mori,Yukinori Koga,Mineharu Sugimoto
Shunsuke Mori
We treated 21 patients with organizing pneumonia (OP) associated with rheumatoid arthritis (RA) or related to biological disease-modifying antirheumatic drugs (DMARDs) at our institution between 2006 and 2014. Among these cases, 3 (14.3%) p...
Hiroshi Kitazawa,Shigeo Kure
Hiroshi Kitazawa
Interstitial lung disease (ILD) in childhood is a heterogeneous group of rare pulmonary conditions presenting chronic respiratory disorders. Many clinical features of ILD still remain unclear, making the treatment strategies mainly investig...
Yasuhiro Katsumata,Yasushi Kawaguchi,Hisashi Yamanaka
Yasuhiro Katsumata
The association between interstitial lung disease (ILD) and anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), particularly microscopic polyangiitis (MPA), has been described in a number of case reports and case series...
Management of Rheumatoid Arthritis Patients with Interstitial Lung Disease: Safety of Biological Antirheumatic Drugs and Assessment of Pulmonary Fibrosis [0.03%]
类风湿关节炎合并间质性肺病患者的治疗：生物改善病情抗风湿药的安全性和肺纤维化评估
Shunsuke Mori
Shunsuke Mori
Interstitial lung disease (ILD) is one of the major causes of morbidity and mortality of patients with rheumatoid arthritis (RA). Accompanying the increased number of reports on the development or exacerbation of ILD in RA patients followin...
Pneumocystis jirovecii Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis Recommendations [0.03%]
类风湿关节炎患者的肺炎支原体肺炎的预防和治疗建议
Shunsuke Mori,Mineharu Sugimoto
Shunsuke Mori
Pneumocystis jirovecii infection causes fulminant interstitial pneumonia (Pneumocystis pneumonia, PCP) in patients with rheumatoid arthritis (RA) who are receiving biological and/or nonbiological antirheumatic drugs. Recently, we encountere...
Pneumocystis Pneumonia in Human Immunodeficiency Virus-infected Adults and Adolescents: Current Concepts and Future Directions [0.03%]
人类免疫缺陷病毒感染的成人和青少年肺孢子菌肺炎：当前概念与未来方向
Sadatomo Tasaka
Sadatomo Tasaka
Pneumocystis jirovecii pneumonia (PCP) is one of the most common opportunistic infections in human immunodeficiency virus-infected adults. Colonization of Pneumocystis is highly prevalent among the general population and could be associated...
Recent Treatment of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies [0.03%]
近年间质性肺病与自身免疫性肌炎的治疗进展
Hidenaga Kawasumi,Takahisa Gono,Yasushi Kawaguchi et al.
Hidenaga Kawasumi et al.
Interstitial lung disease (ILD) is a prognostic factor for poor outcome in polymyositis (PM)/dermatomyositis (DM). The appropriate management of ILD is very important to improve the prognosis of patients with PM/DM. ILD activity and severit...
Pulmonary Hypertension an Independent Risk Factor for Death in Intensive Care Unit: Correlation of Hemodynamic Factors with Mortality [0.03%]
危重症患者肺动脉高压与死亡的独立危险因素：血流动力学因素与病死率的相关性分析
Ghulam Saydain,Aamir Awan,Palaniappan Manickam et al.
Ghulam Saydain et al.
Objective: Critically ill patients with pulmonary hypertension (PH) pose additional challenges due to the existence of right ventricular (RV) dysfunction. The purpose of this study was to assess the impact of hemodynamic ...
Hiroshi Furukawa,Shomi Oka,Kota Shimada et al.
Hiroshi Furukawa et al.
Interstitial lung disease (ILD) is a chronic, progressive fibrotic lung disease with a dismal prognosis. ILD of unknown etiology is referred to as idiopathic interstitial pneumonia (IIP), which is sporadic in the majority of cases. ILD is f...
Normalization of lung function following treatment of secondary usual interstitial pneumonia: a case report [0.03%]
治疗继发性普通间质肺炎后肺功能的正常化：病例报告
Laurie A Hohberger,Felicia Montero-Arias,Anja C Roden et al.
Laurie A Hohberger et al.
Usual interstitial pneumonia (UIP) is the most common idiopathic interstitial pneumonia (IIP) and is associated with a poor prognosis and poor responsiveness to immunosuppressive therapy. We present a case of a woman with steroid-responsive...